Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) hit a new 52-week low during trading on Tuesday . The stock traded as low as $7.57 and last traded at $7.65, with a volume of 33841 shares traded. The stock had previously closed at $7.36.
Evotec Stock Up 3.9 %
The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The firm’s 50-day moving average is $7.36 and its 200 day moving average is $8.71. The stock has a market cap of $2.53 billion, a price-to-earnings ratio of 17.95 and a beta of 0.98.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
See Also
- Five stocks we like better than Evotec
- How to Calculate Inflation Rate
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What is the Nikkei 225 index?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Invest in Blue Chip Stocks
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
